Johnson & Johnson considers deal to buy Shockwave Medical, WSJ reports By Reuters Johnson & Johnson considers deal to buy Shockwave Medical, WSJ reports…
Want Decades of Passive Income? 2 Stocks to Buy Now. There arent many guarantees in the equity market, but the dividend payouts of Johnson & Johnson and Abbott Laboratories may…
Johnson & Johnson Aktie: Umsatzwachstum Prognostiziert Johnson & Johnson (JNJ), der weltgrößte Hersteller von Gesundheitsprodukten, hat kürzlich die FDA-Zulassung für Edurant erhalten und wird in naher…
Nvidia and Johnson & Johnson to develop new AI applications for surgery Johnson & Johnson MedTech and Nvidia are developing new artificial intelligence applications for surgery.…
Global Bone Graft and Substitutes Market Analysis by Product, Application, and Competitive Landscape 2023-2033 Featuring Medtronic, Globus Medical, and Johnson & Johnson Among Others Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Global Bone Graft and Substitutes Market: Focus on Product, Application,…
Johnson & Johnson Aktie: Aufschwung Trotz Herausforderungen Die Aktie von Johnson & Johnson hat im Laufe des vergangenen Jahres eine positive Entwicklung von +8,0% verzeichnet, was im…
Top Stock Reports for UnitedHealth, Johnson & Johnson & Oracle Todays Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Johnson & Johnson (JNJ)…
Global Recombinant Vaccine Market Size To Exceed USD 24.9 Billion By 2032 | CAGR of 11.75% The Global Recombinant Vaccine Market Size was Valued at USD 8.2 Billion in 2023 and the Worldwide Recombinant Vaccine Market…
Acinetobacter Pneumonia Therapeutics Market to Reach USD 927.1 Million to 2031 Companies covered in this study are Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc (GSK), AstraZeneca plc, Novartis AG, Johnson…
Ambrx Biopharma shareholders approve Johnson & Johnson merger By Investing.com Ambrx Biopharma shareholders approve Johnson & Johnson merger…
Ambrx Shareholders Approve Acquisition by Johnson & Johnson SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Ambrx Biopharma, Inc., (“Ambrx” or the “Company”) (NASDAQ: AMAM), today…
Johnson & Johnson submits application to the European Medicines Agency for DARZALEX® (daratumumab)-based quadruplet therapy for the treatment of patients with transplant-eligible, newly diagnosed multiple myeloma Submission supported by data from Phase 3 PERSEUS study, which showed the daratumumab subcutaneous formulation-based regimen significantly reduced the risk…
Johnson & Johnson: Jüngster Talkum-Prozess von J&J endet ohne Urteil Ein Mann hatte gegen J&J wegen einem auf Talkum basierenden Babypuder geklagt. Es hätte bei seiner Frau tödlichen Eierstockkrebs verursacht.…
Johnson & Johnson (JNJ) Management presents at Cowen 44th Annual Health Care Conference (Transcript) …
Will Johnson & Johnson Be a Trillion-Dollar Stock by 2030? Can Johnson & Johnson stock become a hot buy for growth-focused investors, or is this mainly just a dividend play?…
Johnson & Johnson Stock Has 33% Upside, According to 1 Wall Street Analyst Managements thesis regarding the spinoff is now being tested.…
Expecting a Market Downturn? Protect Your Portfolio With These Dividend Champions Stocks Analysis by Investing.com (Damian Nowiszewski) covering: Exxon Mobil Corp, Johnson & Johnson, Johnson & Johnson Co, Exxon Mobil Corporation.…